NCT03590366: A trial that was reported late by AOBiome LLC
This trial has reported, although it was 158 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03590366 |
|---|---|
| Title | A Vehicle-Controlled, Double-Blind, Randomized Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Rosacea |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 2, 2018 |
| Completion date | Feb. 11, 2019 |
| Required reporting date | Feb. 11, 2022, midnight |
| Actual reporting date | July 19, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 158 |